D-0487-2015 Class III Terminated

Recalled by Apotex Inc. — Toronto, N/A

FDA drug recall D-0487-2015 was initiated by Apotex Inc. on Feb 12, 2015 and is designated Class III. Reason for recall: CGMP Deviations: Product excipient was not re-tested at the appropriate date. The recall status is terminated (terminated Dec 30, 2016). Affected quantity: 33,795 Bottles.

Recall details

Product Type
Drugs
Report Date
Apr 22, 2015
Initiation Date
Feb 12, 2015
Termination Date
Dec 30, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
33,795 Bottles

Product description

Bromfenac Ophthalmic Solution 0.09%, Rx Only. Mfg For: Apotex Corp., Weston, FL, 33326. Available in a) 1.7 mL Bottle, NDC: 60505-0595-5; b) 2 x 1.7 mL Bottles, NDC: 60505-0595-6; c) 2.5 mL Bottles, NDC: 60505-0596-4.

Reason for recall

CGMP Deviations: Product excipient was not re-tested at the appropriate date.

Distribution pattern

U.S. Nationwide.

Code information

a) Lot #: KY8498, Expiry: 01/2016; b) Lot #: KY8496, Expiry: 01/2016; c) Lot #: MC5426, Expiry: 02/2016; Lot #: KZ2002, Expiry: 04/2016.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0487-2015
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0487-2015. Report a data issue: hello@regdatalab.com.